Proteomics

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Proteomics

Competitor Analysis: Anti-Obesity Peptides and Biologics Price Site License $524.00 Global License $786.00 Publication Date: Feb 2012 Format: PDF Pages: 28 Publisher: La Merie The present Competitive Intelligence Report about Anti-Obesity Peptides and Biologics used to treat obesity and metabolic syndrome provides a competitor evaluation in the field of R&D projects with anti-obesity peptides and biologics as of February 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. The database also contains information about discontinued projects. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. More...

Therapeutic Proteins Market to 2017 - High Demand for Monoclonal Antibodies will Drive the Market Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 01-Sep-2011 Format: PDF Pages: 142 Publisher: GBI Research More...

Competitor Analysis: Cardiovascular Peptides Price Site License $802.00 Global License $1,203.00 Publication Date: Dec 2011 Format: PDF Pages: 45 Publisher: La Merie The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, arrhythmias, hypertension, peripheral and cerebral vascular diseases, and hematologic disorders provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. More...

Competitor Analysis: Anti-Infective Peptides Price Site License $802.00 Global License $1,203.00 Publication Date: Dec 2011 Format: PDF Pages: 44 Publisher: La Merie The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective peptides as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. More...

Therapeutic Protein Pipeline Database: 1-Year Subscription Price Single User $1,613.00 Site License $3,226.00 Global License $4,838.00 Format: Online Database Publisher: La Merie Subscription to La Merie’s proprietary Therapeutic Protein Pipeline Database provides online access to more than 1,700 project entries for therapeutic proteins on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic proteins is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously by passive and active searches. Information from press releases is entered on a daily basis. Active searches for targets, indications, company pipelines, scientific congresses, corporate releases, publications and in other sources is conducted on a rotating, regular basis. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major products are provided. The projects can be segmented into Territories, Therapeutic Areas and R&D Phases. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database More...

Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 01-Dec-2010 Format: PDF Pages: 124 Publisher: GBI Research Sample Pages GBI Research, the leading business intelligence provider, has released its latest report, “Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics” that provides key data, information and analysis of the major trends and issues in Personalized Medicine Market. The report provides a comprehensive insight into the role of Human Genomics and Proteomics to challenge traditional therapeutics. The report also provides a detailed analysis of market characterization of personalized medicine market in terms of its market size, segmentation by key geography types and the major market drivers and barriers. The report also talks about the patent landscape for human genomics and proteomics and provides comprehensive analysis. More...

Innovations In Epigenetics: Advances in Technologies, Diagnostics & Therapeutics Price: $3,835.00 (€3,002.69) ($4,602.00 (€3,603.22) Including VAT at 20%) Publication Date: 01-Nov-2009 Please click here for more information or to purchase this report at our partner store This report identifies the leading companies at the forefront of epigenetic research that will drive the market to develop a new generation of therapies and diagnostics. It provides case studies of these firms developing epigenetic treatments to address cancer, neurodegenerative and infectious diseases.

Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook Price: $3,835.00 (€3,002.69) ($4,602.00 (€3,603.22) Including VAT at 20%) Publication Date: 01-Mar-2010 Please click here for more information or to purchase this report at our partner store This report discusses the drivers, restraints, challenges and opportunities in the global diagnostics market for genomics, proteomics and metabolomics on the basis of technologies, applications, and strategic issues and innovations. The key factor in the current scenario for next-generation omics-based diagnostic technologies is the level of accuracy in the results, followed by the capacity for early detection, and costs.

Biomarkers in Late-Stage Clinical Trials: Applications, opportunities and activities of leading players Price: $3,835.00 (€3,002.69) ($4,602.00 (€3,603.22) Including VAT at 20%) Publication Date: 01-Apr-2010 Please click here for more information or to purchase this report at our partner store This report reviews various biomarker technologies and therapy area applications, with market drivers and restraints viewed in the context of the biomarker activity of leading innovator companies as well as contract research organizations. The report also describes the strategic focus of the market players by evaluating the competitive landscape.

Bone Morphogenic Proteins: Future Therapeutic Applications Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 11-Feb-2010 Format: PDF Pages: 21 Publisher: GlobalData More...

Biomarkers - Advanced Technologies and Global Market (2009-2014) Price Single User (+$4,650.00) Multi User (+$5,650.00) Corporate Licence (+$7,150.00) Enterprise Site Licence (+$9,000.00) Published: 9/9/2009 Pages: 167 Format: pdf Author: MarketsandMarkets Table of Contents The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and also evaluates the major trends in the macro- and micro-markets with respect to different geographic regions. The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014, driven by the high demand for the biomarkers in the field of drug discovery. The markets for biomarker tools and services are expected to grow at a CAGR of 18.5% and 22.2% respectively. The increasing use of biomarkers in clinical services is boosting the overall biomarker service market. More...

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Proteomics

© 2012 MarketReports.com  Contact Us | Privacy Policy | Terms & Conds